Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Proof of concept study of an apoptosis-signal regulating kinase (ASK1) inhibitor (selonsertib) in combination with an acetyl-CoA carboxylase inhibitor (GS-0976) or a farnesoid X receptor agonist (GS-9674) in NASH Lawitz, E., Herring, R., Younes, Z. H., Gane, E., Ruane, P., Schall, R. A., Jia, C., Xu, R., Mccolgan, B., Djedjos, S., Subramanian, M., Mchutchison, J. G., Myers, R., Middleton, M., Li, K., Hellerstein, M., Kwo, P., Noureddin, M., Harrison, S. ELSEVIER SCIENCE BV. 2018: S57
View details for DOI 10.1016/S0168-8278(18)30335-0
View details for Web of Science ID 000461068600118